AzTrials
AzTrials

Oral HealthCPOPNCT04001933

CenteringPregnancy Oral Health Promotion

A study testing CPOP Intervention in people with Oral Health, run by University of California, San Francisco.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

A five-year, Phase III, multi-site, cluster randomized controlled clinical trial will evaluate the efficacy of the CenteringPregnancy (CP) Oral Health Promotion (CPOP) intervention. Intervention and control groups will be drawn from 6 CP sites. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Oral Health
What is being tested?
CPOP Intervention
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
Aug 2020to 31 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Women:
  • speak, read, or write in English or Spanish
  • enrolled in CP prenatal group care identified as study group
  • free of any condition that requires them to take antibiotic or antibacterial medication prior to dental procedures
  • provide informed consent
  • Babies:
Show all 9Show fewer
  • healthy with no acute or chronic medical conditions, especially those conditions that may have resulted in hospitalizations and subsequent exposure to pathologic microorganisms
  • free of any condition requiring antibiotic treatment currently or within the past three months.
  • mothers provide informed consent for their children at baseline

Who cannot join

  • none

About this study

Official title: CenteringPregnancy Oral Health Promotion (CPOP) Clinical Trial

A five-year, Phase III, multi-site, cluster randomized controlled clinical trial will evaluate the efficacy of the CenteringPregnancy (CP) Oral Health Promotion (CPOP) intervention. Intervention and control groups will be drawn from 6 CP sites. Prenatal care facilitators will conduct the intervention in group prenatal care sessions. With an average of 4 CP facilitators per site (24 facilitators), conducting 2-3 CP groups each (48-72 CP groups with 8 mother/child dyads per group), the total study population will be approximately 384 dyads. CP facilitators will be randomly assigned to either the: 1) intervention arm and deliver the CPOP intervention; or 2) control arm and deliver the usual CP curriculum. The CPOP intervention consists of two 15-minute modules: 1) maternal oral health (OH) and 2) infant OH. The data collection will continue through 12 months postpartum. For the maternal OH module, pre- and post-intervention dental exams of gingival OH and Plaque Levels, and knowledge, attitudes and behavior (KAB) questionnaires during the prenatal period will be used to assess maternal OH outcomes. For the infant OH module, pre and post-module KAB questionnaires will be completed during the prenatal period. Infant OH risk status - the presence of caries-causing bacteria (mutans streptococci and Lactobacilli) in saliva of both mother and infant will be assessed when the infant is 12 months of age to determine differences in study arms.

Conditions
Oral Health
Being tested
CPOP Intervention
Keywords
Pregnancy, Oral Health, Maternal Oral Health, Infant Oral Health

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CPOP InterventionOther

    The intervention consists of two 15-minute interactive modules (maternal and infant OH), integrated into 2 group prenatal care sessions. Led by trained prenatal care providers (facilitators), the maternal module includes discussion of common OH problems during pregnancy, importance of OH, importance and safety of OH care during pregnancy, hands-on skills-building activities of learning and practicing proper tooth brushing and self-assessment of gum health, and presentation of illustrated flossing and OH promotion guides. The infant module includes discussion of infant oral hygiene, avoiding saliva sharing, proper nutrition, and importance of a dental visit by the first birthday. Activities in both modules utilize separate tool kits including tooth brushes, fluoride toothpaste, and other supplies.

Study groups in NCT04001933
Study groupRoleWhat they receive
Intervention ArmExperimentalCPOP Intervention (see below).
Receives: Other: CPOP Intervention
Control ArmNo interventionUsual care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in percent of periodontal probing sites that bleed upon probing

    Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in the percent of periodontal probing sites that bleed upon probing.

    Measured: 12 weeks follow-up

  2. Change in percent of periodontal probing sites that probe at ≥4mm depth

    Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in the percent of periodontal probing sites that probe at ≥4mm depth.

    Measured: 12 weeks follow-up

  3. Change in plaque levels at 24 sites

    Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in plaque levels at 24 sites (4 sites on 6 teeth) using the Plaque Index. Each site is scored from 0-3 (0=no plaque; 3=heavy plaque), yielding a score between 0 and 72.

    Measured: 12 weeks follow-up

  4. Incidence of salivary Mutans Streptococci in infants at 12 months of age

    Based on results of assays of infant saliva specimens collected at 12 months of age, comparisons between infants whose mothers were in the Intervention versus the Control groups will be conducted to determine differences in the incidence of Mutans Streptococci.

    Measured: 1-year follow-up postpartum

Secondary outcomes (12)
  1. Change in maternal oral health knowledge

    Self reported oral health knowledge questionnaire which includes 12 dichotomous items (0-1) for a total between 0 and 12 used for comparisons between the Intervention and Control groups.

    Measured: 12 week follow-up

  2. Change in maternal oral health attitude

    Self reported oral health attitude questionnaire which includes 8 items scored 1-4 (1=Not at all important; 4=Very important) for a total between 8 and 32 used for comparisons between the Intervention and Control groups.

    Measured: 12 week follow-up

  3. Change in maternal oral health behavior

    Self reported oral health behavior questionnaire which includes 4 items scored as either correct or incorrect (0=Incorrect; 1=Correct) for a total between 0-4 used for comparisons between the Intervention and Control groups.

    Measured: 12 week follow-up

  4. Change in maternal knowledge regarding infant oral health

    Self reported infant oral health knowledge questionnaire which includes 10 dichotomous items (0-1) for a total between 0 and 10 used for comparisons between the Intervention and Control groups.

    Measured: 2 week follow-up

  5. Change in maternal attitude regarding infant oral health

    Self reported infant oral health attitude questionnaire which includes 8 items scored 1-4 (1=Not at all important; 4=Very important) for a total between 8 and 32 used for comparisons between the Intervention and Control groups.

    Measured: 2 week follow-up

  6. Incidence of salivary Lactobacillus in infants at 12 months of age

    Based on results of assays of infant saliva specimens collected at 12 months of age, comparisons between infants whose mothers were in the Intervention versus the Control groups will be conducted to determine differences in the incidence of Lactobacillus.

    Measured: 1 year follow-up postpartum

  7. Mediation outcomes for maternal oral health are maternal oral health knowledge

    Evaluation of maternal oral health knowledge as a mediator of the association between treatment arm and plaque, probing and bleeding.

    Measured: 12 week follow-up

  8. Mediation outcomes for maternal oral health are maternal oral health attitudes (importance and self-efficacy)

    Evaluation of maternal oral health attitudes as a mediator of the association between treatment arm and plaque, probing and bleeding.

    Measured: 12 week follow-up

  9. Mediation outcomes for maternal oral health are maternal oral health behaviors (ADA-recommended tooth brushing practices and flossing)

    Evaluation of maternal oral health behaviors as a mediator of the association between treatment arm and plaque, probing and bleeding.

    Measured: 12 week follow-up

  10. Mediation outcomes for infant oral health risk are infant oral health-related knowledge

    Evaluation of maternal knowledge of infant oral health as a mediator of the association between treatment arm and infant MS and LB.

    Measured: 1 year follow-up postpartum

  11. Mediation outcomes for infant oral health risk are infant oral health-related attitudes (importance and self-efficacy)

    Evaluation of maternal attitudes toward infant oral health as a mediator of the association between treatment arm and infant MS and LB.

    Measured: 1 year follow-up postpartum

  12. Mediation outcomes for infant oral health risk are infant oral health-related behaviors (importance and self-efficacy)

    Evaluation of maternal behaviors toward infant oral health as a mediator of the association between treatment arm and infant MS and LB.

    Measured: 1 year follow-up postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2019
  2. Study startAug 2020 (estimated)
  3. Primary completionJul 2022 (estimated)
  4. Study completion31 Jul 2022

Why it stopped: The onset of COVID-19 shut down San Francisco in March 2020, resulting in immediate suspension of group prenatal care at our clinic sites. This continued suspension prevented the conduct of study activities, which resulted in study termination.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04001933
Sponsor's protocol ID
18-029-E
Other IDs
1U01DE027340-01
Acronym
CPOP
Status last verified
Jan 2023
First submitted
4 Jun 2019
Last updated
23 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CPOP Intervention in people with Oral Health, run by University of California, San Francisco.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 23 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in percent of periodontal probing sites that bleed upon probing (time frame: 12 weeks follow-up). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in